Sanam Loghavi, Associate Professor

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Abbvie
    Date added:
    01/17/2023
    Date updated:
    09/09/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Guidepoint
    Date added:
    01/17/2023
    Date updated:
    09/09/2024
    Relationship end date:
    04/21/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    QualWorld
    Date added:
    01/17/2023
    Date updated:
    09/09/2024
    Relationship end date:
    05/12/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    GLG
    Date added:
    01/17/2023
    Date updated:
    09/09/2024
    Relationship end date:
    08/30/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Abbvie
    Date added:
    01/17/2023
    Date updated:
    09/09/2024
    Relationship end date:
    08/08/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Daiichi Sankyo
    Date added:
    01/17/2023
    Date updated:
    09/09/2024
    Relationship end date:
    09/26/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Caris
    Date added:
    01/17/2023
    Date updated:
    09/09/2024
    Relationship end date:
    11/04/2022
  • Attribution:
    Self
    Type of financial relationship:
    Travel
    Ineligible company:
    Mission Bio
    Date added:
    01/17/2023
    Date updated:
    09/09/2024
    Relationship end date:
    11/03/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    OncLive
    Date added:
    01/17/2023
    Date updated:
    09/09/2024
    Relationship end date:
    12/12/2022
Return to 2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice